IDERA Trademark

Trademark Overview

On Tuesday, June 28, 2005, a trademark application was filed for IDERA with the United States Patent and Trademark Office. The USPTO has given the IDERA trademark a serial number of 78660224. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, February 24, 2021. This trademark is owned by Hybridon, Inc.. The IDERA trademark is filed in the Pharmaceutical Products category with the following description:

Medical therapeutic preparations, namely, biologically active modulators, biologically active immune modulators, [ biologically active antisense DNA or RNA compounds, ] chemical modulators of gene expression working at DNA transcription, RNA or translation processes; immunomodulatory oligonucleotides, namely, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; pharmaceuticals for use in the treatment of viral and bacterial infection, inflammatory disorders and diseases, asthma or allergies, cancer, and auto immune diseases and disorders and vaccine adjuvants to modulate the immune system; biologically active pharmaceutical compounds for use in the treatment of viral and bacterial infection or diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents or cellular genes
idera

General Information

Serial Number78660224
Word MarkIDERA
Filing DateTuesday, June 28, 2005
Status800 - REGISTERED AND RENEWED
Status DateWednesday, February 24, 2021
Registration Number3684484
Registration DateTuesday, September 15, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 31, 2006

Trademark Statements

Goods and ServicesMedical therapeutic preparations, namely, biologically active modulators, biologically active immune modulators, [ biologically active antisense DNA or RNA compounds, ] chemical modulators of gene expression working at DNA transcription, RNA or translation processes; immunomodulatory oligonucleotides, namely, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; pharmaceuticals for use in the treatment of viral and bacterial infection, inflammatory disorders and diseases, asthma or allergies, cancer, and auto immune diseases and disorders and vaccine adjuvants to modulate the immune system; biologically active pharmaceutical compounds for use in the treatment of viral and bacterial infection or diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents or cellular genes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 21, 2020
Primary Code005
First Use Anywhere DateMonday, June 2, 2008
First Use In Commerce DateMonday, June 2, 2008

Trademark Owner History

Party NameIDERA PHARMACEUTICALS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02139
Party NameIDERA PHARMACEUTICALS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02139
Party NameIDERA PHARMACEUTICALS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02139
Party NameHybridon, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Wednesday, February 24, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, February 24, 2021REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, February 24, 2021REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, February 22, 2021TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Monday, August 24, 2020POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Friday, August 21, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 21, 2020REINSTATED
Friday, August 21, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 21, 2020PETITION TO DIRECTOR - GRANTED
Monday, August 17, 2020TEAS RESPONSE TO PETITION TO DIRECTOR INQUIRY
Wednesday, July 29, 2020PETITION INQUIRY LETTER ISSUED
Tuesday, July 28, 2020ASSIGNED TO PETITION STAFF
Monday, April 6, 2020TEAS PETITION TO DIRECTOR RECEIVED
Friday, March 27, 2020NOTICE OF CANCELLATION SEC. 8 EMAILED
Thursday, March 26, 2020CANCELLED SEC. 8 (10-YR)
Wednesday, September 25, 2019POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Tuesday, September 24, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, September 16, 2019TEAS SECTION 8 & 9 RECEIVED
Tuesday, April 23, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 23, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, September 15, 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, October 27, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, October 27, 2015REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, October 27, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, September 10, 2015TEAS SECTION 8 & 15 RECEIVED
Tuesday, September 15, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, August 11, 2009LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, August 10, 2009ASSIGNED TO LIE
Friday, July 31, 2009ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, July 28, 2009STATEMENT OF USE PROCESSING COMPLETE
Monday, July 6, 2009USE AMENDMENT FILED
Tuesday, July 28, 2009EXTENSION 5 GRANTED
Monday, July 6, 2009EXTENSION 5 FILED
Tuesday, July 28, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 6, 2009TEAS EXTENSION RECEIVED
Monday, July 6, 2009TEAS STATEMENT OF USE RECEIVED
Thursday, January 15, 2009EXTENSION 4 GRANTED
Thursday, January 15, 2009EXTENSION 4 FILED
Thursday, January 15, 2009TEAS EXTENSION RECEIVED
Wednesday, July 23, 2008EXTENSION 3 GRANTED
Wednesday, July 23, 2008EXTENSION 3 FILED
Wednesday, July 23, 2008TEAS EXTENSION RECEIVED
Friday, February 8, 2008EXTENSION 2 GRANTED
Wednesday, January 23, 2008EXTENSION 2 FILED
Wednesday, January 23, 2008TEAS EXTENSION RECEIVED
Tuesday, July 3, 2007EXTENSION 1 GRANTED
Tuesday, July 3, 2007EXTENSION 1 FILED
Tuesday, July 3, 2007TEAS EXTENSION RECEIVED
Tuesday, January 23, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 31, 2006PUBLISHED FOR OPPOSITION
Wednesday, October 11, 2006NOTICE OF PUBLICATION
Friday, September 15, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 8, 2006ASSIGNED TO LIE
Tuesday, September 5, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 15, 2006AMENDMENT FROM APPLICANT ENTERED
Friday, July 28, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 28, 2006PAPER RECEIVED
Monday, January 30, 2006NON-FINAL ACTION E-MAILED
Monday, January 30, 2006NON-FINAL ACTION WRITTEN
Thursday, January 19, 2006ASSIGNED TO EXAMINER
Tuesday, July 5, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

idera immune biologically active diseases modulators pharmaceutical treatment system response viral